carnitine has been researched along with Autoimmune Thrombocytopenia in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " Previous reports indicate that ELT is mainly eliminated in the liver, although its pharmacokinetic profile has not yet been clarified in detail." | 1.37 | Pharmacokinetics and hepatic uptake of eltrombopag, a novel platelet-increasing agent. ( Horikawa, M; Ishiwata, N; Kato, Y; Matsubara, K; Nakamichi, N; Silver, DL; Sugiura, T; Takeuchi, K; Umeda, S, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Takeuchi, K | 1 |
| Sugiura, T | 1 |
| Umeda, S | 1 |
| Matsubara, K | 1 |
| Horikawa, M | 1 |
| Nakamichi, N | 1 |
| Silver, DL | 1 |
| Ishiwata, N | 1 |
| Kato, Y | 1 |
1 other study available for carnitine and Autoimmune Thrombocytopenia
| Article | Year |
|---|---|
Pharmacokinetics and hepatic uptake of eltrombopag, a novel platelet-increasing agent.
Topics: Animals; Benzoates; Blood Platelets; Cell Line; Dose-Response Relationship, Drug; Hepatocytes; Human | 2011 |